Themis Medicare Ltd Gains 1.51%: 2 Key Factors Driving the Week’s Volatility

27 January: Stock Hits 52-Week Low Amid Continued Downtrend

Themis Medicare Ltd’s shares declined sharply on 27 January 2026, falling 1.58% to close at Rs.78.05, marking a fresh 52-week low intraday at Rs.77.15. This decline extended a two-day losing streak, with the stock down 3.81% cumulatively over that period. The fall occurred despite a broadly positive market environment, as the Sensex gained 0.50% to 35,786.84 points.

The stock’s underperformance relative to the Pharmaceuticals & Biotechnology sector and the broader market was notable, with Themis trading below all key moving averages including the 5-day, 20-day, 50-day, 100-day, and 200-day averages. This technical positioning underscores persistent bearish sentiment.

Financially, the company continues to face headwinds, reporting a loss of Rs.6.69 crore in Profit Before Tax excluding other income for the latest quarter, a 152.0% deterioration compared to the previous four-quarter average. Net sales contracted by 26.85% over the last six months to Rs.175.57 crore, with a corresponding loss of Rs.17.84 crore in Profit After Tax. These results have contributed to the stock’s weak momentum and a Strong Sell rating by MarketsMOJO with a Mojo Score of 17.0.

28 January: Strong Gap Up Signals Short-Term Rebound

Following the prior day’s decline, Themis Medicare Ltd opened with a significant gap up on 28 January 2026, surging 6.85% at the open and reaching an intraday high of Rs.83.40. The stock closed at Rs.80.80, up 3.52% on the day, outperforming both its sector by 2.86% and the Sensex’s 1.12% gain.

This gap up marked a short-term reversal after two consecutive days of losses, reflecting a shift in market sentiment. However, the stock remained below all major moving averages, indicating that the broader bearish technical context persists. Technical indicators such as the MACD and Bollinger Bands remain bearish on weekly and monthly timeframes, while the RSI showed a bullish signal on the weekly chart but no clear monthly trend.

Themis Medicare’s high beta of 1.89 relative to the SMLCAP index suggests heightened volatility, consistent with the sharp price swings observed. Despite the positive price action, the stock’s 1-month performance remains weak, down 20.65%, highlighting ongoing medium-term challenges.

29 January: Price Retraces Amid Mixed Market Signals

On 29 January, Themis Medicare Ltd’s stock price retraced 1.98% to close at Rs.79.20, following the previous day’s strong rebound. This decline occurred despite the Sensex rising modestly by 0.22% to 36,266.59 points, indicating a divergence from broader market trends.

The volume surged to 11,975 shares, suggesting increased trading activity amid uncertainty. The retracement may reflect profit-taking or a test of support levels after the gap up, consistent with the technical caution signalled by bearish MACD and Bollinger Bands readings.

30 January: Week Ends on Positive Note with Modest Gain

Themis Medicare Ltd closed the week on a positive note, gaining 1.64% to Rs.80.50 on 30 January 2026. This rise came despite the Sensex declining 0.22% to 36,185.03 points, indicating relative strength in the stock on the final trading day of the week.

Volume moderated to 5,202 shares, and the stock remained below key moving averages, maintaining a cautious technical outlook. The week’s overall 1.51% gain contrasts with the Sensex’s 1.62% rise, reflecting the stock’s continued underperformance relative to the broader market.

Key Takeaways

Themis Medicare Ltd’s week was characterised by significant volatility, with the stock hitting a 52-week low before staging a strong gap up rebound. Despite this recovery, the stock remains technically weak, trading below all major moving averages and exhibiting bearish momentum indicators on weekly and monthly charts.

Financially, the company continues to face challenges with shrinking sales and sustained losses, reflected in its Strong Sell rating and low Mojo Score of 17.0. The stock’s high beta of 1.89 indicates susceptibility to amplified price swings, contributing to the observed volatility.

Relative to the Sensex, Themis underperformed slightly over the week, gaining 1.51% compared to the index’s 1.62% rise. The gap up on 28 January suggests short-term buying interest, but the sustainability of this move remains uncertain given the broader bearish technical context and fundamental headwinds.

Conclusion

Themis Medicare Ltd’s share price movements this week reflect a stock grappling with fundamental weaknesses and technical challenges amid a volatile market backdrop. The fresh 52-week low on 27 January underscored ongoing financial pressures, while the subsequent gap up on 28 January indicated a tentative short-term recovery. However, the stock’s position below key moving averages and bearish momentum indicators suggest that caution remains warranted.

Investors should note the stock’s high beta and the persistence of losses, which contribute to its Strong Sell rating by MarketsMOJO. While the week ended with a modest gain, Themis Medicare Ltd continues to face significant hurdles in regaining sustained upward momentum relative to the broader market and its sector peers.

Unlock special upgrade rates for a limited period. Start Saving Now →